South Korea
· Delayed Price · Currency is KRW IL Science Statistics
Total Valuation
IL Science has a market cap or net worth of KRW 70.31 billion. The enterprise value is 150.61 billion.
| Market Cap | 70.31B |
| Enterprise Value | 150.61B |
Important Dates
The next estimated earnings date is Friday, March 21, 2025.
| Earnings Date | Mar 21, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
IL Science has 27.04 million shares outstanding. The number of shares has increased by 8.37% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 27.04M |
| Shares Change (YoY) | +8.37% |
| Shares Change (QoQ) | -39.32% |
| Owned by Insiders (%) | 27.39% |
| Owned by Institutions (%) | n/a |
| Float | 19.36M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.93 |
| PB Ratio | 5.04 |
| P/TBV Ratio | 13.07 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -19.57 |
| EV / Sales | 2.03 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -12.95 |
Financial Position
The company has a current ratio of 0.49, with a Debt / Equity ratio of 4.18.
| Current Ratio | 0.49 |
| Quick Ratio | 0.31 |
| Debt / Equity | 4.18 |
| Debt / EBITDA | n/a |
| Debt / FCF | -7.26 |
| Interest Coverage | -0.91 |
Financial Efficiency
Return on equity (ROE) is -30.74% and return on invested capital (ROIC) is -5.26%.
| Return on Equity (ROE) | -30.74% |
| Return on Assets (ROA) | -3.88% |
| Return on Capital (ROIC) | -5.26% |
| Revenue Per Employee | 1.37B |
| Profits Per Employee | -142.48M |
| Employee Count | 54 |
| Asset Turnover | 0.65 |
| Inventory Turnover | 6.89 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -23.92% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -23.92% |
| 50-Day Moving Average | 2,946.30 |
| 200-Day Moving Average | 2,989.45 |
| Relative Strength Index (RSI) | 38.94 |
| Average Volume (20 Days) | 74,008 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, IL Science had revenue of KRW 74.19 billion and -7.69 billion in losses. Loss per share was -316.16.
| Revenue | 74.19B |
| Gross Profit | 16.58B |
| Operating Income | -7.14B |
| Pretax Income | -5.94B |
| Net Income | -7.69B |
| EBITDA | -2.77B |
| EBIT | -7.14B |
| Loss Per Share | -316.16 |
Balance Sheet
The company has 10.32 billion in cash and 84.39 billion in debt, giving a net cash position of -74.07 billion or -2,738.92 per share.
| Cash & Cash Equivalents | 10.32B |
| Total Debt | 84.39B |
| Net Cash | -74.07B |
| Net Cash Per Share | -2,738.92 |
| Equity (Book Value) | 20.18B |
| Book Value Per Share | 515.98 |
| Working Capital | -51.93B |
Cash Flow
In the last 12 months, operating cash flow was -5.41 billion and capital expenditures -6.21 billion, giving a free cash flow of -11.63 billion.
| Operating Cash Flow | -5.41B |
| Capital Expenditures | -6.21B |
| Free Cash Flow | -11.63B |
| FCF Per Share | -429.97 |
Margins
Gross margin is 22.35%, with operating and profit margins of -9.62% and -10.37%.
| Gross Margin | 22.35% |
| Operating Margin | -9.62% |
| Pretax Margin | -8.01% |
| Profit Margin | -10.37% |
| EBITDA Margin | -3.73% |
| EBIT Margin | -9.62% |
| FCF Margin | n/a |
Dividends & Yields
IL Science does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -8.37% |
| Shareholder Yield | -8.37% |
| Earnings Yield | -12.16% |
| FCF Yield | -16.54% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
IL Science has an Altman Z-Score of 0.1. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 0.1 |
| Piotroski F-Score | n/a |